Reference
Ishihara T, et al. Suppressed Fibrinolytic Activity Demonstrated By Simultaneous Thrombin and Plasmin Generation Assay during Cytokine Release Syndrome after CD19 Chimeric Antigen Receptor-Modified T-Cell Therapy. Blood 138 (Suppl. 1): 4807-4809, 23 Nov 2021. Available from: URL: http://doi.org/10.1182/blood-2021-146311 [abstract]
Rights and permissions
About this article
Cite this article
Anti-CD19-CAR-transduced-T-cells. Reactions Weekly 1889, 31 (2022). https://doi.org/10.1007/s40278-022-08710-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-08710-4